<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04093310</url>
  </required_header>
  <id_info>
    <org_study_id>RC19_0179</org_study_id>
    <nct_id>NCT04093310</nct_id>
  </id_info>
  <brief_title>Cost-utility Analysis Treatment of Bartholin's Abscess : Word Catheter Versus Incision-drainage.</brief_title>
  <acronym>BARTHO-KT</acronym>
  <official_title>Cost-utility Analysis Treatment of Bartholin's Abscess : Word Catheter Versus Incision-drainage.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bartholin's gland abscess is a condition requiring emergency consultation. Placement of a
      Word catheter, which is a minor technique used in France as a treatment of bartholin's
      Abscess, can be done in an emergency room without hospitalization. Actually,
      incision-drainage, which is the most widespread treatment in France, is performed on day
      surgery with or without overnight hospitalization. Our hypothesis is that the use of Word
      catheter compared to incision-drainage would not modify the quality of life of the patients
      but would allow a saving of up to 3 M€ per year in France.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cost-utility ratio, according to the societal perspective of the of the management of Bartholin's gland abscess by the Word catheter compared to the incision-drainage</measure>
    <time_frame>12 months</time_frame>
    <description>The utility will be measured by:
Quality Adjusted Life Year (QALYs) as estimated from responses to the Euroqol-5 Dimensions (EQ-5D 5L) health-related quality of life questionnaire. The questionnaire focuses on 5 dimensions: mobility, personal autonomy, current activities, pain/discomfort and anxiety/depression. For each of these dimensions, 5 answers are possible.
The costs will be measured by the addition of the following costs:
Outpatient resource consumption collected in a declarative patient questionnaire. Hospital care resources using the the database of the Medicalised Information System Program of each recruiting site</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Budget impact analysis for the health insurance point of view in case of diffusion of the Word catheter</measure>
    <time_frame>5 years</time_frame>
    <description>Comparison of intervention costs on the study sample and projection of these costs over 5 years, from the health insurance and hospital perspectives</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non inferiority evaluation of Word catheter vs. Incision drainage in terms of pain</measure>
    <time_frame>at baseline and day 1</time_frame>
    <description>Pain numeric scale from 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non inferiority evaluation of Word catheter versus incision-drainage in terms of recurrence rate</measure>
    <time_frame>12 months</time_frame>
    <description>Number of homolateral recurrences of Bartholin's abscess, declared by the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Word catheter versus incision-drainage concerning pain</measure>
    <time_frame>12 months</time_frame>
    <description>Pain numeric scale from 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Word catheter versus incision-drainage concerning management time</measure>
    <time_frame>Day 0 (procedure day), Day 1</time_frame>
    <description>Date and time of patient initial management (randomization) Date and time of the beginning of the procedure date and time of the end of the procedure date and time of the hospital departure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Word catheter versus incision-drainage in terms of complications</measure>
    <time_frame>12 months</time_frame>
    <description>number of complications related to the procedure (healing complications, infection, lost of the Word catheter), contro-lateral Bartholin's abscess occurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Word catheter versus incision-drainage in terms of surgical failure</measure>
    <time_frame>Immediate post-operative (D0) and one month</time_frame>
    <description>Word catheter: insertion failure, loss, removal decision (from the patient or the surgeon) Incision-drainage: incomplete drainage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Word catheter versus incision-drainage in terms of impact on sexual activity</measure>
    <time_frame>Baseline, one month, 6 months and 12 months</time_frame>
    <description>Score of the Female Sexual Function Index: self-questionnaire including 19 questions assessing different parameters of the sexual activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Word catheter versus incision-drainage in terms of quality of life using the SF-12-HS</measure>
    <time_frame>Baseline, one month, 6 months and 12 months</time_frame>
    <description>Short-Form-12-Health-Survey questionnaire score: self-questionnaire including 12 questions measuring different aspects of quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Word catheter versus incision-drainage in terms of quality of life using the EQ-5D</measure>
    <time_frame>Baseline, one day, one month, 3 months, 6 months, 9 months and 12 months</time_frame>
    <description>EQ-5D 5L score (described in primary outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Word catheter versus incision-drainage in terms global patient impression and improvement</measure>
    <time_frame>One day, one month, 3 months, 6 months, 9 months and 12 months</time_frame>
    <description>Patient Global Impression and Improvement (PGI-I) global index used to rate the response of a condition to a therapy (transition scale). It is a single question asking the patient to rate their global condition now, as compared with how it was prior to before beginning treatment on a scale from 1 - very much better to 7 - very much worse</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">302</enrollment>
  <condition>Bartholin's Gland Abscess Treatment</condition>
  <arm_group>
    <arm_group_label>Word catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The abscess is incised and the Word catheter is inserted into the residual cavity to create a neo-channel to prevent recurrence. The catheter is removed after 4 weeks during a consultation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Incision-drainage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This procedure performed under general or loco-regional anaesthesia consists in incising the abscess, draining the pus build-up and placing a wick in the residual cavity to promote progressive healing from the inside out.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Word Catheter</intervention_name>
    <description>Use of the Word catheter to remove the Bartholin's abscess</description>
    <arm_group_label>Word catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Incision-drainage</intervention_name>
    <description>Incision-drainage to remove the Bartholin's abscess</description>
    <arm_group_label>Incision-drainage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Abscess of Bartholin's gland Patient able to understand the protocol Patient who signed
        informed consent Patient with social insurance

        Exclusion Criteria:

        Spontaneous fistulization of the abscess before surgical treatment Abscess volume under 3
        ml Medical treatment which avoid incision or word catheter placement patients under
        guardianship Unable to complete questionnaires Patients not affiliated to social protection
        regimen Pregnant or post-partum women (until 4 weeks after delivery)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thibault Thubert, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thibault Thubert, PhD</last_name>
    <phone>+33 2 53 48 24 43</phone>
    <email>thibault.thubert@chu-nantes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cécile DERT</last_name>
    <phone>+33 2 53 48 28 52</phone>
    <email>cecile.dert@chu-nantes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GUILLAUME LEGENDRE, MD</last_name>
      <phone>0241354459</phone>
      <email>GUILLAUME.LEGENDRE@CHU-ANGERS.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU CAEN</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ANNE CECILE PIZZOFERRATO, MD</last_name>
      <phone>0231063106</phone>
      <email>ACPIZZOFE@GMAIL.COM</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ch Antoine Beclere</name>
      <address>
        <city>Clamart</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xavier DEFFIEUX, MD</last_name>
      <phone>0145374444</phone>
      <email>XAVIER.DEFFIEUX@APHP.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Estaing</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>SANDRINE CAMPAGNE LOISEAU, MD</last_name>
      <phone>0473750621</phone>
      <email>SCAMPAGNE-LOISEAU@CHU-CLERMONTFERRAND.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Franco Britannique</name>
      <address>
        <city>Levallois-Perret</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CAROLINE TRICHOT, MD</last_name>
      <phone>0685541983</phone>
      <email>TRICHOTCARO@GMAIL.COM</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Lille</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GERALDINE GIRAUDET, MD</last_name>
      <phone>0320446584</phone>
      <email>GERALDINE.GIRAUDET@CHRU-LILLE.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>thibault THUBERT, md</last_name>
      <phone>0647697800</phone>
      <email>thibault.thubert@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Caremeau</name>
      <address>
        <city>Nîmes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>VINCENT LETOUZEY, MD</last_name>
      <phone>0662576010</phone>
      <email>VINCENT.LETOUZEY@CHU-NIMES.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ch Kremlin Bicetre</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Perrine CAPMAS, MD</last_name>
      <phone>0145217590</phone>
      <email>Perrine.capmas@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Cochin</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PAUL MARZOUK, MD</last_name>
      <phone>0158413681</phone>
      <email>PAUL.MARZOUK@APHP.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Robert Debre</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>THOMAS SCHMITZ, MD</last_name>
      <phone>0140032000</phone>
      <email>THOMAS.SCHMITZ@APHP.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chi Poissy</name>
      <address>
        <city>Poissy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ARNAUD FAUCONNIER, MD</last_name>
      <phone>0139274004</phone>
      <email>AFAUCONNIER@CHI-POISSY-ST-GERMAIN.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>AMELIE CHARVERIAT, MD</last_name>
      <phone>0549444444</phone>
      <email>A.CHARVERIAT@GMAIL.COM</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chu Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FABIEN VIDAL, MD</last_name>
      <phone>0567771111</phone>
      <email>DOX_94@YAHOO.FR</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 16, 2019</study_first_submitted>
  <study_first_submitted_qc>September 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2019</study_first_posted>
  <last_update_submitted>January 24, 2020</last_update_submitted>
  <last_update_submitted_qc>January 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>incision-drainage</keyword>
  <keyword>Bartholin's abscess</keyword>
  <keyword>Word catheter</keyword>
  <keyword>Marsupialization</keyword>
  <keyword>Cost-utility analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abscess</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

